Skip to contentW
Whitehawk Therapeutics, Inc.
W
WHWKWhitehawk Therapeutics, Inc. Released Aug 13, 2015, during market hours
10-Q filed Aug 13, 2015, 44 days after period end · 0001213900-15-006039
Q2 2015 · 10-Q
Revenue—
Net Income-$7.27K-$7.27KN/M vs Q2 2014N/M vs Q1 2015 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
$0.00$0.00— vs Q2 2014no prior Q1 2015 on file Operating Income-$5,103N/M Operating Cash Flowderived-$13,192N/M Filing lag
ended Jun 30, 2015 · filed Aug 13, 2015 · 44 d after period end